Trials / Not Yet Recruiting
Not Yet RecruitingNCT07042490
Efficacy and Safety of Plasma Adsorption Combined With EVT for AIS-LVO
Efficacy and Safety of Plasma Adsorption Combined With Endovascular Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion of Anterior Circulation: A Multicenter, Randomized, Parallel-controlled Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Yi Yang · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of plasma adsorption for patients of acute ischemic stroke who underwent endovascular thrombectomy due to large vessel occlusion of anterior circulation.
Detailed description
Large vessel occlusive (LVO) stroke has a higher mortality and disability rate than other types of acute ischemic stroke (AIS). Endovascular thrombectomy (EVT) is recommended as a standard treatment for AIS-LVO. However, even if the blood vessels are successfully recanalization, nearly one-third of the patients still die and nearly half remain disabled at 3 months. Inflammation plays a crucial role in the pathophysiological cascade of ischemic stroke and related forms of brain injury. Evidence from experimental stroke indicates that targeting cytokines may reduce infarct volume and promote functional recovery. Plasma adsorption (PA) has been applied in the treatment of severe inflammatory diseases, including pancreatitis and sepsis, as well as in the neurological autoimmune diseases, such as myasthenia gravis, multiple sclerosis, and autoimmune encephalitis. We hypothesize that PA can improve functional outcome of AIS-LVO who underwent EVT. In this study, the experimental group receive EVT and PA, 1 time per day for 3 consecutive days. The control group receive EVT . Two groups will be followed up for 90 days to evaluate the efficacy and safety of PA for patients of AIS-LVO of anterior circulation, who achieve successful recanalization through EVT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Plasma adsorption | Plasma adsorption was initiated after endovascular thrombectomy once daily for 3 days. |
| PROCEDURE | Endovascular Thrombectomy | The patients will be treated with endovascular thrombectomy. |
Timeline
- Start date
- 2025-06-30
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2025-06-29
- Last updated
- 2025-06-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07042490. Inclusion in this directory is not an endorsement.